Medicinal Plants Extracts with Antiangiogenic Activity: Where Is the Link?

Zohreh Hoseinkhani1, Fathemeh Norooznezhad1, Mohsen Rastegari-Pouyani2

  • 1Medical Biology Research Center Medical Sciences, Health Technology Institute, Kermanshah, Iran.

Insights

This review explores natural plant compounds that inhibit angiogenesis, the process of new blood vessel formation crucial for tumor growth. These plant-derived agents offer a promising complementary strategy to chemotherapy for cancer treatment.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Angiogenesis, the formation of new blood vessels, is vital for physiological processes but also critical for tumor growth, development, and metastasis.
  • Inhibiting angiogenesis is a key anticancer strategy, often used alongside chemotherapy to improve patient outcomes.
  • Certain natural plant compounds have demonstrated the ability to inhibit angiogenesis and cancer cell proliferation.

Purpose of the Study:

  • To review and introduce plants exhibiting anti-angiogenic properties.
  • To discuss the features and mechanisms of these plant-derived anti-angiogenic compounds.
  • To highlight the potential of natural products as complementary cancer therapies.

Main Methods:

  • Literature review of scientific studies on plant-derived compounds and their anti-angiogenic effects.
  • Analysis of research investigating the impact of these compounds on tumor blood vessel formation.
  • Compilation of data on the efficacy of these natural agents against cancer cell growth and proliferation.

Main Results:

  • Several plant-derived compounds have shown significant anti-angiogenic activity.
  • These compounds effectively inhibit the formation of new blood vessels within tumors.
  • Many also demonstrate direct anti-proliferative effects on cancer cells.

Conclusions:

  • Natural plant compounds represent a valuable resource for developing novel anti-angiogenic cancer therapies.
  • These agents can potentially enhance the effectiveness of conventional treatments like chemotherapy.
  • Further research into plant-derived anti-angiogenic agents is warranted for their clinical application in oncology.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K